All Stories

  1. Study of secondary porosity by SAXS and N 2 adsorption in composite materials obtained from a Cuban natural clinoptilolite
  2. Silver complexes with fluoroanthranilic acid isomers: Spectroscopic characterization, antimycobacterial activity and cytotoxic studies over a panel of tumor cells
  3. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
  4. Zeolite/ZnO composites based on a Cuban natural clinoptilolite and preliminary evaluation in methylene blue adsorption
  5. Biguanide–transition metals complexes as potential drug for hyperglycemia treatment
  6. Chain-like uranyl-coordination polymer as a bright green light emitter for sensing and sunlight driven photocatalysis
  7. Chemical transformation of a luminescent two-dimensional Eu(iii) coordination polymer in the aqueous phase
  8. Crystal structure, anti-Trypanosoma cruzi and cytotoxic activities of Cu(II) complexes bearing β-diketone and α-diimine ligands
  9. New Allyldithiocarbimates: Synthesis, Structure and Antifungal Activity against Phakopsora pachyrhizi and Hemileia vastatrix
  10. Synthesis and solid-state characterization of diclofenac imidazolium monohydrate: an imidazolium pharmaceutical ionic liquid
  11. “Half-Sandwich”/RuII Anticancer Complexes Containing Triphenylphosphine and p-Substituted Benzoic Acids
  12. Green One-Pot Asymmetric Synthesis of Peptidomimetics via Sequential Organocatalyzed Aziridination and Passerini Multicomponent Reaction
  13. Data of synthesis, characterization and luminescence measurements in 1D lanthanide coordination polymers based on lanthanides
  14. Synthesis, spectroscopic (FT–IR and UV–Vis), crystallographic and theoretical studies, and a molecular docking simulation of an imatinib-like template
  15. Green Synthetic Methodology of (E)-2-cyano-3-aryl Selective Knoevenagel Adducts Under Microwave Irradiation
  16. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
  18. Crystal structures of two CuII compounds: catena-poly[[chloridocopper(II)]-μ-N-[ethoxy(pyridin-2-yl)methylidene]-N′-[oxido(pyridin-3-yl)methylidene]hydrazine-κ4 N,N′,O:
  19. 1D lanthanide coordination polymers based on lanthanides and 4′-hydroxi-4-biphenylcarboxylic acid: Synthesis, structures and luminescence properties
  20. Synthesis, structural characterization, and theoretical studies of new pyrazole (E)-2-{[(5-(tert-butyl)-1H-pyrazol-3-yl)imino]methyl}phenol and (E)-2-{[(1-(4-bromophenyl)-3-(tert-butyl)-1H-pyrazol-5-yl]imino]methyl}phenol
  21. Isolation, Identification, Predictions of Biological Activity and Molecular Docking of the Diterpene Jateorin Obtained from the Stem of Odontocarya tamoides (D.C.) Miers
  22. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
  23. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
  24. Nickel complexes with phosphines and N-R-sulfonyldithiocarbimates ligands: New antifungals for the control of Hemileia vastatrix and Phakopsora pachyrhizi
  25. Fluconazole: Synthesis and Structural Characterization of Four New Pharmaceutical Cocrystal Forms
  26. Esterification of the free carboxylic group from the lutidinic acid ligand as a tool to improve the cytotoxicity of Ru(ii) complexes
  27. X-ray diffraction, vibrational and thermal study of dibenzazepinodione, a pharmacopeial impurity of oxcarbazepine
  28. Fluconazolium oxalate: synthesis and structural characterization of a highly soluble crystalline form
  29. When Serendipity Knocks on the Door: Synthesis and Physicochemical Characterization of 7-Chloro-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidin-5-one
  30. Pharmaceutical paroxetine-based organic salts of carboxylic acids with optimized properties: the identification and characterization of potential novel API solid forms
  31. Supramolecular synthesis and characterization of crystalline solids obtained from the reaction of 5-fluorocytosine with nitro compounds
  32. Highly water soluble agrichemicals by using engineered organic salts for reducing adverse environmental impacts
  34. In vitro Antiplasmodial Activities of Alkaloids Isolated from Roots of Worsleya procera (Lem.) Traub (Amaryllidaceae)
  35. In vitro anti-Trypanosoma cruzi activity of ternary copper(II) complexes and in vivo evaluation of the most promising complex
  36. In vitro cytotoxicity and in vivo zebrafish toxicity evaluation of Ru(ii)/2-mercaptopyrimidine complexes
  37. Spergulagenic Acid A: Isolation and single crystal structure elucidation
  38. Modulating the water solubility and thermal stability of the anti-tuberculosis drug Isoniazid via multicomponent crystal formation
  39. Development of copper(II)-diimine-iminodiacetate mixed ligand complexes as potential antitumor agents
  40. The use of variable temperature 13 C solid-state MAS NMR and GIPAW DFT calculations to explore the dynamics of diethylcarbamazine citrate
  41. In vitro leishmanicidal activity and theoretical insights into biological action of ruthenium(II) organometallic complexes containing anti-inflammatories
  42. Rational Design of a Famotidine–Ibuprofen Coamorphous System: An Experimental and Theoretical Study
  43. Crystal Structure of N-(2-Cyano-1-Phenylprop-2-en-1-yl)-4-Methylbenzenesulfonamide
  44. Mechanochemical Synthesis of a Multicomponent Solid Form: The Case of 5-Fluorocytosine Isoniazid Codrug
  45. Synthesis, crystal structure, photophysical properties and theoretical studies of a novel bis(phenylisoxazolyl) benzene derivative
  46. Co-crystal structure of a dinuclear (Zn-Y) and a trinuclear (Zn-Y-Zn) complexes derived from a Schiff base ligand
  47. 5-Fluorocytosine/5-Fluorouracil Drug-Drug Cocrystal: a New Development Route Based on Mechanochemical Synthesis
  48. Protonation of inorganic 5-Fluorocytosine salts
  49. Synthesis, characterization and solubility of a new anthelmintic salt: Mebendazole nitrate
  50. Novel Solid Solution of the Antiretroviral Drugs Lamivudine and Emtricitabine
  51. Cytotoxic activity and structural features of Ru(II)/phosphine/amino acid complexes
  52. Paroxetine and Fluoxetine Hexafluorosilicate salts: Synthesis, crystal structure, Hirshfeld surface, and supramolecular analysis
  53. {1-[1-(2-Hydroxyphenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}{1-[1-(2-oxidophenyl)ethylidene]-2-(pyridin-2-yl-κN)hydrazine-κ2 N′,O}nickelate(...
  54. Antimicrobial activity of cis -[Ru(bpy) 2 (L)(L′)] n + complexes, where L = 4-(4-chlorobenzoyl)pyridine or 4-(benzoyl)pyridine and L′ = Cl − or CO
  55. Crystalline structure of the marketed form of Rifampicin: a case of conformational and charge transfer polymorphism
  56. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations
  57. Ru(ii)–thyminate complexes: new metallodrug candidates against tumor cells
  58. A vanillin-based copper(ii) metal complex with a DNA-mediated apoptotic activity
  59. Avoiding irreversible 5-fluorocytosine hydration via supramolecular synthesis of pharmaceutical cocrystals
  60. Facile Synthesis and Characterization of Symmetric N-[(Phenylcarbonyl) carbamothioyl]benzamide Thiourea: Experimental and Theoretical Investigations
  61. Exploring physical and chemical properties in new multifunctional indium-, bismuth-, and zinc-based 1D and 2D coordination polymers
  62. Crystal engineering of multicomponent crystal forms of antituberculosis drugs
  63. Crystallochemical characterization of polyoxometalate new minerals
  64. Synthesis, characterization and reactivity of halides/pseudohalides and their complexes containing ruthenium II in the hydrogenation of cyclohexene
  65. Conformational and structural diversity of iridium dimethyl sulfoxide complexes
  66. Probing intermolecular interactions in a diethylcarbamazine citrate salt by fast MAS 1 H solid-state NMR spectroscopy and GIPAW calculations
  67. Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
  68. Spectroscopic (far or terahertz, mid-infrared and Raman) investigation, thermal analysis and biological activity of piplartine
  69. Synthesis, structural characterization and cytotoxic activity against tumor cells of heteroleptic copper (I) complexes with aromatic diimines and phosphines
  70. Ru(II)/diphenylphosphine/pyridine-6-thiolate complexes induce S-180 cell apoptosis through intrinsic mitochondrial pathway involving inhibition of Bcl-2 and p53/Bax activation
  71. Photochemical studies of cis -[Ru(bpy) 2 (4-bzpy)(CO)](PF 6 ) 2 and cis -[Ru(bpy) 2 (4-bzpy)(Cl)](PF 6 ): Blue light-induced nucleobase binding
  72. Ruthenium(II)/triphenylphosphine complexes: An effective way to improve the cytotoxicity of lapachol
  73. Development of a salt drug with improved solubility: Ethionamide nitrate
  74. Propyl gallate metal complexes: Circular dichroism, BSA-binding, antioxidant and cytotoxic activity
  75. Hydroxycalciomicrolite, Ca1.5Ta2O6(OH), a new member of the microlite group from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  76. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms
  77. Reactive nitrogen/oxygen species production by nitro/nitrosyl supramolecular ruthenium porphyrin complexes
  78. Copper(I)–Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity
  79. Syntheses, characterization and antifungal activity of novel dimethylbis(N-R-sulfonyldithiocarbimato)stannate(IV) complexes
  80. Order–disorder phase transition induced by proton transfer in a co-crystal of 2,4-dichlorobenzoic acid and trimethylamine N-oxide
  81. A Potential Visible-Light NO Releaser: Synthesis, Reactivity and Vasodilator Properties
  82. Polypyridyl Ruthenium Complexes: Novel DNA-Intercalating Agents against Human Breast Tumor
  83. Structural isomerism of Ru(ii)-carbonyl complexes: synthesis, characterization and their antitrypanosomal activities
  84. Studies on the Ru(II) monocationic complexes [RuCl 2 (NO)(P–N)(PR 3 )]PF 6 , where P–N = o -diphenylphosphino- N , N -dimethylaniline, and R = Ph and p -X-C 6 H 4 (X = OMe, Me, F)
  85. Ru(II)/bisphosphine/diimine/amino acid complexes: diastereoisomerism, cytotoxicity, and inhibition of tumor cell adhesion to collagen type I
  86. Correction to Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  87. Solution and Solid State Nuclear Magnetic Resonance Spectroscopic Characterization of Efavirenz
  88. X-Ray diffraction, spectroscopy and thermochemical characterization of the pharmaceutical paroxetine nitrate salt
  89. Diffractaic acid: Crystalline structure and physicochemical characterization
  90. On the Thermal Stability of the Diethylcarbamazine-Fortified Table Salt Used in the Control of Lymphatic Filariasis
  91. Rare Case of Polymorphism in a Racemic Fluoxetine Nitrate Salt: Phase Behavior and Relative Stability
  92. Centrosymmetric resonance-assisted intermolecular hydrogen bonding chains in the enol form of β-diketone: Crystal structure and theoretical study
  93. Syntheses, characterization and antifungal activity of heteroleptic nickel(II) complexes with N-alkylsulfonyldithiocarbimates and phosphines
  94. Cationic Pd(II) complexes acting as topoisomerase II inhibitors: Synthesis, characterization, DNA interaction and cytotoxicity
  95. Reversible Solid-State Hydration/Dehydration of Paroxetine HBr Hemihydrate: Structural and Thermochemical Studies
  96. Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study
  97. Tetraphenylphosphonium allyldithiocarbimates derived from Morita-Baylis-Hillman adducts: Synthesis, characterization, crystal structure and antifungal activity
  98. Tuning the structure, dimensionality and luminescent properties of lanthanide metal–organic frameworks under ancillary ligand influence
  99. Supramolecular synthesis and thermochemical investigations of pharmaceutical inorganic isoniazid salts
  100. Rare earth coordination dinuclear compounds constructed from 3,5-dicarboxypyrazolate and succinate intermetallic bridges
  101. Influence of gold nanoparticles applied to catalytic hydrogenation of acetophenone with cationic complexes containing ruthenium
  102. Mechanochemistry applied to reformulation and scale-up production of Ethionamide: Salt selection and solubility enhancement
  103. Luminescence, chemical sensing and mechanical properties of crystalline materials based on lanthanide–sulfonate coordination polymers
  104. Chiral Platinum(II) Complexes Featuring Phosphine and Chloroquine Ligands as Cytotoxic and Monofunctional DNA-Binding Agents
  105. Crystal structure of 4-formyl-2-nitrophenyl 4-chloro-2-nitrobenzoate
  106. Crystal structure of 2-(4-chlorobenzamido)benzoic acid
  107. Cis-[RuCl(BzCN)(N–N)(P–P)]PF6 complexes: Synthesis and in vitro antitumor activity
  108. Vibrational and thermal analyses of multicomponent crystal forms of the anti-HIV drugs lamivudine and zalcitabine
  109. Exploring the System Lanthanide/Succinate in the Formation of Porous Metal–Organic Frameworks: Experimental and Theoretical Study
  110. Crystal structure and catalytic activity of ruthenium (II)/dithiocarbamate complexes in the epoxidation of cyclooctene
  111. Copper(II) complexes with β-diketones and N-donor heterocyclic ligands: Crystal structure, spectral properties, and cytotoxic activity
  112. Isostructurality and the conformational role of the 2′,3′-moieties in the diversity of lamivudine crystal forms probed in halide salts
  113. Anti-Mycobacterium tuberculosisand Cytotoxicity Activities of Ruthenium(II)/Bipyridine/Diphosphine/Pyrimidine-2-thiolate Complexes: The Role of the Non-CoordinatedN-Atom
  114. Ruthenium(II) complexes with hydroxypyridinecarboxylates: Screening potential metallodrugs against Mycobacterium tuberculosis
  115. Crystal Growth & Design Celebrates the International Year of Crystallography 2014
  116. DFT investigation on hydrogen bonding in cyclohexane-1,2,3,4,5-pentol crystal structure
  117. Crystal structure of 4-bromo-N-(2-hydroxyphenyl)benzamide
  118. Crystal structure of 2-nitro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  119. Crystal structure of (±)-3-[(benzo[d][1,3]dioxol-5-yl)methyl]-2-(3,4,5-trimethoxyphenyl)-1,3-thiazolidin-4-one
  120. Temperature-Driven Isosymmetric Reversible Phase Transition of the Hormone Estradiol 17β Valerate
  121. Solid-State Supramolecular Synthesis Based on the N–H…O Heterosynthon: An Approach to Solve the Polymorphism Problem in Famotidine
  122. Saddle-shaped macrocycle distortion and symmetry decrease in cobalt (II) meso-tetraphenylporphyrin: Structure of a dichloromethane solvate and DFT calculations
  123. Effect of the Methanol Molecule on the Stabilization of C 18 H 18 O 4 Crystal: Combined Theoretical and Structural Investigation
  124. Structural features and cytotoxic activities of [Ru(AA-H)(dppb)(bipy)]PF6 complexes
  125. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)–dipeptide–phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer
  126. Controlled Synthesis of New 5-Fluorocytosine Cocrystals Based on the p K a Rule
  127. Nitro/Nitrosyl-Ruthenium Complexes Are Potent and Selective Anti-Trypanosoma cruzi Agents Causing Autophagy and Necrotic Parasite Death
  128. Modified glassy carbon electrode with AuNPs using cis-[RuCl(dppb)(bipy)(4-vpy)]+ as crossed linking agent
  129. Antiparasitic activities of novel ruthenium/lapachol complexes
  130. fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbonyl(1,10-phenanthroline-κ2N,N′)rhenium(I) hexafluoridophosphate acetonitrile monosolvate
  131. [4-(Allyloxy)phenyl](phenyl)methanone
  132. 2,4,6-Trinitrophenyl 3-bromobenzoate
  133. 2-[(1-Oxidopyridin-4-yl)sulfanyl]benzoic acid
  134. 3-(Diphenylamino)isobenzofuran-1(3H)-one
  135. Synthesis, characterization and phytotoxic activity of hydroxylated isobenzofuran-1(3H)-ones
  136. Halogen⋯halogen contacts for the stabilization of a new polymorph of 9,10-dichloroanthracene
  137. 2,2′-(1,4-Phenylene)bis(propane-2,2-diyl) bis(benzodithioate)
  138. Quasi-enantiomeric single-nucleoside and quasi-racemic two-nucleoside hydrochloride salts and ruthenium complexes of cytidine and 2′,3′-dideoxycytidine analogs unveiling the negligible structure-driving role of the 2′,3′-moieties
  139. Unusual hydrogen bond patterns contributing to supramolecular assembly: conformational study, Hirshfeld surface analysis and density functional calculations of a new steroid derivative
  140. Novel polymorphs of the anti-Trypanosoma cruzi drug benznidazole
  141. Ruthenium(II)/4,6-dimethyl-2-mercaptopyrimidine complexes: Synthesis, characterization, X-ray structures and in vitro cytotoxicity activities on cancer cell lines
  142. Structural and vibrational study of 8-hydroxyquinoline-2-carboxaldehyde isonicotinoyl hydrazone – A potential metal–protein attenuating compound (MPAC) for the treatment of Alzheimer’s disease
  143. 4-Formyl-2-nitrophenyl 2-chlorobenzoate
  144. The Continuum in 5-Fluorocytosine. Toward Salt Formation
  145. Mebendazole Mesylate Monohydrate: A New Route to Improve the Solubility of Mebendazole Polymorphs
  146. Fluorcalciomicrolite, (Ca, Na, 〈)2Ta2O6F, a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  147. The effect of guest molecules on the conformation and molecular assembly of the fac-[RuCl3(NO)(dppb)] complex
  148. NH⋯Br, Br⋯π and π⋯π interactions toward self-assembly of the cytosine hydrobromide: Crystal structure, infrared spectroscopy and thermal behavior
  149. 2-[1′-(Benzyloxy)spiro[indane-1,2′-pyrrolidine]-5′-yl]acetonitrile
  150. (±)-3-(5-Amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-benzofuran-1(3H)-one
  151. Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis
  152. 2,4,6-Trinitrophenyl 3-chlorobenzoate
  153. Supramolecular study, Hirshfeld analysis and theoretical study of 6-methoxyquinolineN-oxide dihydrate
  154. 4-Formyl-2-nitrophenyl 4-bromobenzoate
  155. X-ray Crystal Structures of Intermediates of the Stereoselective (±)-Grandisol Synthesis Based on the Remote Alkylation Protocol
  156. 2,2′-(Carbonothioyldisulfanediyl)bis(2-methylpropanoic acid)
  157. Synthesis, crystal structure and photoluminescence of a binuclear complex of europium(III) containing 3,5-dicarboxypyrazolate and succinate
  158. 2,4,6-Trinitrophenyl 4-chlorobenzoate
  159. 5-Chloroquinolin-8-yl furan-2-carboxylate
  160. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co(sulfamethoxazole)2(H2O)2]·H2O
  161. New ruthenium(II)/phosphines/diimines complexes: Promising antitumor (human breast cancer) and Mycobacterium tuberculosis fighting agents
  162. A new copper(II) complex with 2-thenoyltrifluoroacetone and 2,2-bipyridine: Crystal structure, spectral properties and cytotoxic activity
  163. Electrochemical and Monte Carlo studies of self-assembled trans-[Fe(cyclam)(NCS)2]+ complex ion on gold surface as electrochemical sensor for nitric oxide
  164. Hydrokenomicrolite, ( ,H2O)2Ta 2(O,OH)6(H2O), a new microlite-group mineral from Volta Grande pegmatite, Nazareno, Minas Gerais, Brazil
  165. cis-Bis(1,10-phenanthroline-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate)
  166. cis-Bis(2,2′-bipyridine-κ2N,N′)bis(pyridin-4-amine-κN1)ruthenium(II) bis(hexafluoridophosphate) acetonitrile monosolvate
  167. Understanding the Solid Forms of 5E-phenylethenylbenzofuroxan with Differentin vivoanti-T. cruziActivity
  168. 16α-Hydroxyfriedelin and 3-Oxo-16-methylfriedel-16-ene as Building Blocks: Crystal Structure and Hirshfeld Surfaces Decoding Intermolecular Contacts
  169. Novel sesquiterpene lactones from Eremanthus seidelii
  170. Crystal Structure of Limonoid 6-O-Acetylswietephragmin E and Theoretical Study of Nuclear Magnetic Resonance Spectra of Phragmalin Limonoids
  171. 3,5-Bis(benzyloxy)benzoic acid
  172. 2,4,6-Trinitrophenyl 4-methylbenzoate
  173. Base-Paired and Base-Stacked Structures of the Anti-HIV Drug Lamivudine: A Nucleoside DNA-Mimicry with Unprecedented Topology
  174. Synthesis, crystal structure and magnetic properties of the helical oxalate-bridged copper(II) chain {[(CH3)4N]2[Cu(C2O4)2] · H2O}n
  175. Ethyl 2-(3-phenylthioureido)-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxylate
  176. Synthesis and characterization of [Ru(η6-C10H14)(dppf)X][PF6] (X=Cl, Br, I, SnF3) compounds: The X-ray structure of [Ru(η6-C10H14)(dppf)Cl][SnCl3]·0.45CH2Cl2
  177. 2,4,6-Trinitrophenyl 3-methylbenzoate
  178. 6-Bromopyridine-2-carbaldehyde phenylhydrazone
  179. Lamivudine Salts with Improved Solubilities
  180. 9-(4-Bromobutyl)-9H-carbazole
  181. Synthesis and characterization of the atropisomeric relationships of a substituted N-phenyl-bipyrazole derivative with anti-inflammatory properties
  182. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor
  183. Cyclopropane- and spirolimonoids and related compounds from Hortia oreadica
  184. Host–guest interactions between xanthones and water: the role of O–H···O, C–H···O, and π···π contacts in the channel- and cage-type frameworks
  185. Pseudopolymorphism in hydroxybenzophenones: the dihydrate of 2,2′,4,4′-tetrahydroxybenzophenone
  186. Influence of hydrogen bonds on the molecular structure and conformations of two (C30H48O2) pentacyclic triterpene isomers
  187. Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids
  188. Toward supramolecular architectures of the anti-HIV drug lamivudine: understanding the effect of the inclusion of water in a hydrochloride form
  189. Form III-like conformation and Form I-like packing in a chloroform channel solvate of the diuretic drug chlortalidone
  190. X-ray diffraction and theoretical investigation of the Gedunin crystal structure
  191. Preparation, characterization and structure of ruthenium phosphine complexes containing non-innocent ligands
  192. Hydrothermal syntheses of ETS-10 like vanadosilicates using chiral organic molecules. Part I
  193. 4-Methylphenyl 4-bromobenzoate
  194. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis
  195. Syntheses, crystal structure and theoretical investigation of novel heteroleptic complexes of nickel(II) with N-R-sulfonyldithiocarbimate and phosphine ligands
  196. Rankamaite from the Urubu pegmatite, Itinga, Minas Gerais, Brazil: Crystal chemistry and Rietveld refinement
  197. Weak C—H...Cl—Pd interactions toward conformational polymorphism intrans-dichloridobis(triphenylphosphane)palladium(II)
  198. A monoclinic polymorph of the ticlopidine hydrochloride
  199. Crystal structure of the drug diethylcarbamazine and a new maleate salt
  200. Supramolecular chemistry of anti-HIV nucleoside drugs: toward smart crystal phases and self-assembled DNA-mimicries
  201. Asymmetric heterobimetallic mixed-valence complex trans-[(SO3)Co(cyclam)(NCS)Ru(NH3)4(NCS)](BF4): Synthesis and characterization
  202. Experimental and theoretical investigation of molecular structure and conformation of the 4-isopropylthioxanthone
  203. fac-/mer-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine): Synthesis, characterization and DFT calculations
  204. Conformational polymorphism of the antidiabetic drug chlorpropamide
  205. cis-Bis[1,1-dibenzyl-3-(furan-2-ylcarbonyl)thioureato-κ2O,S]copper(II)
  207. Study of the phenanthroline-Mn-imidazole bonding in Mn(I) triscarbonyl complex: A X-ray and DFT computational analysis
  208. cis-Bis{1,1-dibenzyl-3-[(furan-2-yl)carbonyl]thioureato-κ2O,S}nickel(II)
  209. Tetrachlorocarbonyliridates: Water-Soluble Carbon Monoxide Releasing Molecules Rate-Modulated by the Sixth Ligand
  210. Synthesis and Crystal Structures of Octahedral Sn(IV) Complexes Prepared from SnCl2·2H2O and 2-Hydroxyacetophenone (S-benzydithiocarbazate) Ligand (H2L)
  211. 4-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoic acid: X-ray and DFT-calculated structure
  212. Design of 1D and 2D molecule-based magnets with the ligand 4,5-dimethyl-1,2-phenylenebis(oxamato)
  213. Increasing the symmetry of drug crystals: a monoclinic conformational polymorph of the platelet antiaggregating agent ticlopidine hydrochloride
  214. The mer-[RuCl3(dppb)(H2O)] complex: A versatile tool for synthesis of RuII compounds
  215. 2-(Phenylcarbonothioylsulfanyl)acetic acid
  216. 3-Nitrophenol–4,4′-bipyridylN,N′-dioxide (2/1): a DFT study and CSD analysis of DPNO molecular complexes
  217. Triple Structural Transition below Room Temperature in the Antifilarial Drug Diethylcarbamazine Citrate
  218. Coordination of nitro-thiosemicarbazones to ruthenium(II) as a strategy for anti-trypanosomal activity improvement
  219. On the synthesis and structures of the complexes [RuCl(L)(dppb)(N–N)]PF6 (L=CO, py or 4-NH2py; dppb=1,4-bis(diphenylphosphino)butane; N–N=2,2′-bipyridine or 1,10-phenanthroline) and [(dppb)(CO)Cl2-Ru-pz-RuCl2(CO)(dppb)] (pz=pyrazine)
  220. Oxorhenium(V) Complexes with 2,3-Dihydroxynaphthalene
  221. 2-[(2-Carboxyphenyl)disulfanyl]benzoic acid–4,4′-bipyridylN,N′-dioxide (1/2)
  222. ChemInform Abstract: 6-Deoxyjacareubin.
  223. ChemInform Abstract: Serendipitous, One-Pot Formation of 2,3,7-Triphenylcyclopenta[c]pyran from 1,2-Diphenylethanedione (“Benzil”) and Cyclopentadiene.
  224. Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes
  225. Solvothermal Preparation of Drug Crystals: Didanosine
  226. From Rational Design of Drug Crystals to Understanding of Nucleic Acid Structures: Lamivudine Duplex
  227. Structural and magnetic properties of the oxyborateCo5Ti(O2BO3)2
  228. On the relationships between molecular conformations and intermolecular contacts toward crystal self-assembly of mono-, di-, tri-, and tetra-oxygenated xanthone derivatives
  229. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity
  230. Dependence of the product on the P–P ligand in reactions of [RuCl3(NO)(P–P)] complexes (P–P=aromatic diphosphines) with 2-mercaptopyridine
  231. Experimental and theoretical study of the kinetics of dissociation in cis-[RuCl2(P-P)(N-N)] type complexes
  232. Efficient synthesis of benzothiazine and acrylamide compounds
  233. A novel and simple synthetic route for a piperazine derivative
  234. Palladium(II) complexes with thiosemicarbazones: syntheses, characterization and cytotoxicity against breast cancer cells and Anti-Mycobacterium tuberculosis activity
  235. Crystal Engineering of an Anti-HIV Drug Based on the Recognition of Assembling Molecular Frameworks
  236. Structural relationships in the solid state of the anti-chagas agent (E)-phenylethenylbenzofuroxan
  237. Driving forces in substitution reactions of octahedral complexes: The influence of the competitive effect
  238. Synthesis, structural characterization and ex vivo biological properties of a new complex [Cu(propranolol)2]·2H2O, a potential beta-blocker
  239. Imidazolium fumarate
  240. Heterobimetallic compounds [Ru(η5-Cp)(dppf)X] (X = Cl, Br, I and N3): synthesis, electrochemical analysis, and the crystal structure of [Ru(η5-Cp)(dppf)I] [dppf = 1,1′-bis(diphenylphosphino)ferrocene]
  241. Bis(tetraphenylphosphonium) tris[N-(methylsulfonyl)dithiocarbimato(2−)-κ2S,S′]stannate(IV)
  242. Synthesis, characterization, and single crystal X-ray structure of the 1-furoyl-3-cyclohexylthiourea cadmium chloride complex, Cd[C4H3OC(O)NHC(S)NHC6H11]4Cl2
  243. Intermolecular contacts influencing the conformational and geometric features of the pharmaceutically preferred mebendazole polymorph C
  244. Conformational Polymorphism in Racemic Crystals of the Diuretic Drug Chlortalidone
  245. 3-Nitrobenzoic acid–3-methyl-4-nitropyridine 1-oxide (1/1)
  246. On an Electrode Modified by a Supramolecular Ruthenium Mixed Valence (Ru II /Ru III ) Diphosphine-Porphyrin Assembly
  247. Molecular conformation of the racemic indan derivative (±)-1-trans-3-(3,4-dichlorophenyl)-2,3-dihydro-1H-indene-1-carboxamide
  248. 4-{2-[4-(Dimethylamino)phenyl]ethylidene}benzonitrile
  249. Partial magnetic ordering and crystal structure of the ludwigitesCo2FeO2BO3andNi2FeO2BO3
  250. 1-Furoyl-3-[3-(trifluoromethyl)phenyl]thiourea
  251. Diphenyllead(IV) thiosemicarbazonates and pyrazolonates: Synthesis and characterization
  252. Redetermination of 1-benzyl-3-furoyl-1-phenylthiourea
  253. Preparation of Achiral and Chiral (E)-Enaminopyran-2,4-diones and Their Phytotoxic Activity
  254. Spectroscopic Investigation on the Formation of a Dinuclear Me2SO–Ru2-Mercaptopyridine Bridged Complex: [Ru2Cl3(μ-pyS)(μ-dmso)(dmso)4] · 2H2O
  255. Lupeol
  256. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity
  257. Novel 6-methanesulfonamide-3,4-methylenedioxyphenyl-N-acylhydrazones: Orally effective anti-inflammatory drug candidates
  258. Synthesis, structural characterization and conformational aspects of nostoclide analogues
  259. Organotin Complexes of Alizarin and Purpurin
  260. Different coordination modes for disulfoxides towards diorganotin(IV) dichlorides. X-ray crystal structures of 1,2-cis-bis-(phenylsulfinyl)ethene (rac-,cis-cbpse) and adducts [{Ph2SnCl2(meso-bpse)}n] and [{n-Bu2SnCl2(pdtd)}2]
  261. Study of the [Zn(H2O)4CuEDTA]·2H2O Complex, a Potential Trace-metal Supplier: Synthesis, Crystal Structure, Spectroscopic Behavior and Metal Release
  262. Analyzing Ru(III)–dmso and Ru(III)–dms motifs in compounds used in the synthesis of the antimetastatic agents
  263. N-(4-Chlorophenyl)maleimide
  264. Rhenium chelate complexes with maltolate or kojate
  265. Synthesis, characterization, X-ray structure and in vitro antimycobacterial and antitumoral activities of Ru(II) phosphine/diimine complexes containing the “SpymMe2” ligand, SpymMe2=4,6-dimethyl-2-mercaptopyrimidine
  266. Powder X-ray diffraction study of polymorphic drugs: fluconazole and mebendazole
  267. 1-(o-Tolyl)thiourea
  268. N-(2-Furylcarbonyl)piperidine-1-carbothioamide
  269. 1-(2-Furoyl)-3-(o-tolyl)thiourea
  270. Crystal Structure of Garciniaphenone and Evidences on the Relationship between Keto-Enol Tautomerism and Configuration
  271. Hydrogen bonding in 2-(2-oxothiazolidin-3-yl)-4,5-dihydrothiazolium hydrogen sulfate monohydrate
  272. 1-(3-Cyanophenyl)-3-(2-furoyl)thiourea
  273. Quantum-chemical, NMR and X-ray diffraction studies on (±)-1-[3,4-(methylenedioxy)phenyl]-2-methylaminopropane
  274. 1-Furfuryl-3-furoylthiourea
  275. Structure and magnetism of homometallic ludwigites:Co3O2BO3versusFe3O2BO3
  276. Synthesis and Characterization of a New Copper(II) Complex with Nadolol, an Aminoalcoholic Beta-blocker. Crystal Structure of Na[Cu(nadololate)(CO3)] · H2O
  277. N-(3-Chlorophenyl)maleimide
  278. 8-Hydroxy-5,6,7-trimethoxy-2-phenyl-4H-chromen-4-one
  279. Lead(II)-induced formation and coordination of 3,4-dihydro-3-thioxo-1,2,4-triazin-5(2H)-one
  280. Dimethylthallium(III) complexes with picolinic acid and its hydroxyl derivatives
  281. Ruthenium(II) complexes containing N(4)-tolyl-2-acetylpyridine thiosemicarbazones and phosphine ligands: NMR and electrochemical studies of cis–trans isomerization
  282. Crystal Structures and Thermal Behavior of Alkaline Earth Tricyanomethanides
  283. New Ni(II)-sulfonamide complexes: Synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4]·2H2O and [Ni(sulfapyridine)2]
  284. Menezesite, the first natural heteropolyniobate, from Cajati, Sao Paulo, Brazil: Description and crystal structure
  285. Synthesis and Characterization of a New Mebendazole Salt: Mebendazole Hydrochloride
  286. New insights on the Lewis acidity of diorganolead(IV) compounds: Diphenyllead(IV) complexes with N,O,S-chelating ligands
  287. Synthesis of novel O-acylated-D-ribono-1,5-lactones and structural assignment supported by conventional NOESY-NMR and x-ray analysis
  288. Sobre uma degenerescência acidental nos deslocamentos químicos de RMN de 31P{¹H} em complexos difosfínicos de rutênio
  289. Crystalline Structure of Mangiferin, aC-Glycosyl-Substituted 9H-Xanthen-9-one Isolated from the Stem Bark ofMangifera indica
  290. New Pd(II) and Pt(II) complexes with N,S-chelated pyrazolonate ligands: Molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity
  291. Novel manganese (III) porphyrin containing peripheral “[RuCl(dppb)(X-bipy)]+” cations [dppb=1,4-bis(diphenylphosphino)butane and X=–CH3, –OMe, –Cl]. X-ray structure of the cis-[RuCl(dppb)(bipy)(4-Mepy)]PF6 complex
  292. Low-temperature study of a new nevirapine pseudopolymorph
  293. 2-Benzoylpyridine semicarbazone
  294. Synthesis, characterization and crystal structure of a novel thiocyanate–ruthenium(II) complex
  295. Heterobimetallic [Ru(II)/Fe(II)] complexes: On the formation of trans- and cis-[RuCl2(dppf)(diimines)]
  296. Synthesis, characterization, X-ray structure and preliminary in vitro antitumor activity of the nitrosyl complex fac-[RuCl3(NO)(dppf)], dppf=1,1′-bis(diphenylphosphine)ferrocene
  297. Crystal structure, electrochemical and photochemical studies of the trans-[Fe(cyclam)(NO)Cl]Cl2 complex (cyclam=1,4,8,11-tetraazacyclotetradecane)
  298. New lead(II) complexes with N,S-ligands, including a lead pyrazolonate with unusual packing flexibility
  299. Crystal structure and anticonvulsant activity of (±)-1,2:4,5-di-O-isopropylidene-3,6-di-O-(2-propylpentanoyl)-myo-inositol
  300. X-ray structure and EPR behavior of a new dimeric copper(II) complex with 4-amino-N-(5-methoxy-2-pyrimidinyl)benzenesulfonamide
  301. Methyllead(IV) Derivatives Stabilized by DAPTSC2–: Synthesis and Structures of New Diorganolead(IV) Complexes
  302. Novel Gold(I) 7-Azacoumarin Complex:  Synthesis, Structure, Optical Properties, and Cytotoxic Effects
  303. Synthesis and structural characterization of two nostoclide analogues
  304. Correlation between quadrupole splitting (Δ) and the θ angle (C–Sn–C) in five-coordinate diphenyltin(IV) complexes. X-ray crystal structures of [Ph2Sn(hacm)] and [Ph2Sn(hacmm)] containing O,N,S-tridentate N 4-heterocyclic thiosemicarbazones
  305. 2,2′,4-Trihydroxybenzophenone: Crystal Structure, and Anti-Inflammatory and Antioxidant Activities
  306. Physicochemical characterization of deflazacort: Thermal analysis, crystallographic and spectroscopic study
  307. The preparation of new oxoniobium(V) complexes from hydrated Niobium(V) Oxide: the crystal and molecular structure of Oxotris(2-pyridinolato-N-oxide)niobium(V)
  308. Pseudohalides of Main Group Metals: The Alcaline Earth Tricyanomethanides - The Crystal Structures of Calcium and Barium Tricyanomethanide.
  309. Natural polyprenylated benzophenones: keto-enol tautomerism and stereochemistry
  310. The first P–N containing RuCl3NO complex: fac-[RuCl3(NO)(P–N)] (P–N=[o-(N,N-dimethylamino)phenyl]diphenylphosphine)
  311. Novel zwitterionic oxorhenium(V) complexes: synthesis, characterization and crystal structure of [ReOX2(Hdhp)(PPh3)] (X = Cl, Br; H2dhp = 2,3-dihydroxypyridine)
  312. Matioliite, the Mg-analog of burangaite, from Gentil mine, Mendes Pimentel, Minas Gerais, Brazil, and other occurrences
  313. A gold(I) complex with a vitamin K3 derivative: Characterization and antitumoral activity
  314. 7-Amino-1-(3-bromophenyl)-3-cyanopyrazolo[4,3-d]pyrimidine
  315. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests
  316. Structural characterization of a series of new Cu-dipeptide complexes in solid state and in solution
  317. Magnetic properties of copper(II) complexes containing peptides. Crystal structure of [Cu(phe-leu)]
  318. Synthesis, 119Sn Mössbauer spectroscopic studies and X-ray crystal structure determination of new seven-coordinate diorganotin(IV) complexes with S,N,N,N,S-pentadentate Schiff bases derived from 2,6-diacetylpyridine of S-methyl- and S-benzyldithiocarba...
  319. On a ruthenium nitrosyl and monocoordinated biphosphine monoxide complex: Synthesis, characterization and X-ray structure of
  320. Preparation, crystal structure and spectroscopic characterization of nickel(II) complexes with dithiocarbimate derivated of sulfonamides
  321. Copper complexes with heterocyclic sulfonamides: Synthesis, spectroscopic characterization, microbiological and SOD-like activities: Crystal structure of [Cu(sulfisoxazole)2(H2O)4]·2H2O
  322. Structure and Vasorelaxant Activity of Floranol, a Flavonoid Isolated from the Roots ofDioclea grandiflora
  323. Influence of ligands on the isomerization in [RuCl3(NO)(P–P)] complexes, [P–P=R2P(CH2)nPR2 (n=1–3) and R2P(CH2)POR2, PR2–CHCH–PR2, R=Ph and (C6H11)2P-(CH2)2-P(C6H11)2]
  324. Mammeigin
  325. Polymorphism on Leflunomide: Stability and Crystal Structures
  326. The versatility of the 1,4-dithiane ligand towards the coordination chemistry of ruthenium-phosphine complexes
  327. The role of solvent in coordination polymers: The structures of catena-[Hg(μ2-O2PPh2)2] and catena-[Hg(μ2-O2PPh2)2(NC5H5)2]
  328. Experimental and theoretical structure characterization of two isoniazid derivatives: 2,4-Difluoro-N′-isonicotinoylbenzohydrazide and 2,4-dichloro-N′-isonicotinoylbenzohydrazide hydrochloride
  329. Ruthenium Phosphine/Diimine Complexes: Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones.
  330. Bis(diphenylphosphinato-κO)bis(diphenylphosphinic acid-κO)bis(pyridine-κN)mercury(II)
  331. Mono- and dinuclear copper(I) complexes with methyl-substituted pyrimidinethiones
  332. A pentacyclic triterpene from Maytenus imbricata: structure elucidation by X-ray crystallography
  333. Synthesis, characterisation and molecular structure of stannyl derivatives of molybdenum and iron
  334. Zinc(II), cadmium(II) and mercury(II) complexes of the vitamin B1 antagonist oxythiamine
  335. Synthesis, characterization and structure of ruthenium(II) phosphine complexes with N-heterocyclic thiolate ligands
  336. A Crystalline Phase Transition and Optical Properties in a CoIICuII Oxamato-Bridged Ferrimagnetic Chain
  337. Ruthenium Phosphine/Diimine Complexes:  Syntheses, Characterization, Reactivity with Carbon Monoxide, and Catalytic Hydrogenation of Ketones†
  338. The RuCl3(dppb)H2O complex: A new metal-assisted oxidative dehydrogenation of the o-phenylenediamine ligand
  339. Leaf-cutting ants toxicity of limonexic acid and degraded limonoids from Raulinoa echinata.: X-ray structure of epoxy-fraxinellone
  340. Limonoids from Spiranthera odoratissima St. Hil
  341. Synthesis and characterization of nitrosyl complexes containing 4,6-dimethyl-pyrimidine-2-thiolato (‘SpymMe2’) as ligand: [Ru(‘SpymMe2’,-N,-S) (‘SpymMe2’,-S)(NO)(P–P)](PF6) (P–P=1,2-bis(diphenylphosphino)ethane or 1,2-bis(diphenylphosphino)ethylene
  342. Magnetic and structural properties of two open-frameworks Nd(III) adipates
  343. Structural insights of a potential inhibition against leishmania major
  344. Factors determining polymorphism of leflunomide
  345. Magnetic and structural properties of rare earth hybrid frameworks
  346. Experimental electron density of [Cu(phen)2Cl](NO3)(H2O)
  347. An Alternative Method for the Preparation of Diphenylboron Chelates. The Crystal and Molecular Structures of (Pyridine-2-acetyloximato)diphenylboron and (1-Phenylazo-2-naphtholato)diphenylboron
  348. Molecular and Supramolecular Structures of 1-Phenyl-4-phenylacetyl-2-thiosemicarbazide (H2L) and its Complexes with Diphenyllead(IV) Chloride and Acetate
  349. Electron density distribution in the pyroborateMn2B2O5studied by the maximum-entropy method
  350. 5-Nitro-2-furaldehydeN-(hydroxymethyl)semicarbazone
  351. Ruthenium complexes containing the hemilabile ligand PPh2(CH2)P(O)PPh2 (dppmO): reactivity towards CO and X-ray molecular structures of tcc-RuCl2(η2-dppmO)2 and mer-RuCl3(η1,η2-dppmO)2
  352. New pyrone and quinoline alkaloid from Almeidea rubra and their trypanocidal activity
  353. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate — the molecular structure of divinyltin(IV) derivative
  354. Layered poly[μ2-aqua-μ3-dimethylformamide-di-μ3-phenylphosphonato-dipotassium]
  355. Synthesis, characterization, and structure of a new N-nitrosamine of cyclam (1,4,8,11-tetraazacyclotetradecane)
  356. 31P{1H}-n.m.r. as a tool for identification of ruthenium isomers containing PPh3 or 1,4-bis(diphenylphosphino)butane ligands. X-ray structures of the cis-{RuCl2(PPh3)2 [4,4′-(-X)2-2,2′-bipy]} complexes [X=-H, -Me, -SMe and (-Cl, -Me)]
  357. Candesartan cilexetil, an antihypertensive agent containing an extended double ester chain
  358. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].Imine hydrogenation using mono- and binuclear ruth...
  359. Polymeric chains, hydrogen bonds and magnetism in Nd(III) adipates
  360. Aurapten, a coumarin with growth inhibition against Leishmania major promastigotes
  361. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
  362. mer-[RuCl3(P–P)H2O] (P–P=dppb or diop) as a starting material for the synthesis of binuclear complexes. Crystallographic structures of [(dppb)ClRu–μ(Cl)3–RuCl(dppb)] and [(η6-C6H6)Ru–μ(Cl)3–RuCl(dppb)].
  363. Syntheses, characterization and X-ray structure of potassium hydrotris(2-mercaptothiazolyl)borate, KMt, and potassium hydrotris(methimazole)borate, KTm
  364. N2,S-versus N3,S-coordination in thiosemicarbazonate complexes: only a steric influence?
  365. Crystal structure and spectral characterization of dimethylthallium (III) complexes with 2-mercaptonicotinic acid and esters
  366. The effect of the cation substitution on the structural and vibrational properties of Cs2NaGaxSc1−xF6 solid solution
  367. Crystal structure and vibrational spectrum of the NaCaMg2F7 pyrochlore
  368. The synthesis and structural characterisation of [Ru(η-Cp)(dppf)SnBr3]
  369. Synthesis, characterisation and thermal decomposition of tin(IV) dithiocarbamate derivatives – single source precursors for tin sulfide powders
  370. Synthesis, Structural, Spectroscopic and Electrochemical Characterization of New Ruthenium(II) Tetramer Complexes Containing 1,4-Bis(diphenylphosphine)butane and Alterdentate Ligands
  371. Reaction of R(Ph)SnCl2(R=Me, Et) with 2,6-diacetylpyridine bis(thiosemicarbazone) (H2DAPTSC): the crystal structures of [Me(Ph)Sn(HDAPTSC)]Cl·1.25 MeOH and [Et(Ph)Sn(H2DAPTSC)]Cl2·MeOH·H2O
  372. Crystallographic report: Supramolecular structure of 2-aminonicotinatodimethylthallium(III),[TlMe2(2anic)]n
  373. Preparation, crystal structure and spectroscopic characterization of novel N-R-sulfonyldithiocarbimate platinum(II) complexes
  374. The Reaction of Dimethyltin(IV) Dichloride with Thiamine Diphosphate (H2TDP):  Synthesis and Structure of [SnMe2(HTDP)(H2O)]Cl·H2O, and Possibility of a Hitherto Unsuspected Role of the Metal Cofactor in the Mechanism of Vitamin-B1-Dependent Enzymes
  375. Structural, spectroscopic and redox studies of a new ruthenium(III) complex with an imidazole-rich tripodal ligand
  376. The Zn2+salt of pamidronate: a role for water in the metal–cation binding properties of bisphosphonates
  377. Crystallographic report: Ethyltriphenyltin(IV), Et(Ph)3Sn
  378. Potassium tetrakis(2-mercaptothiazolyl)borate; an open-framework material: synthesis and X-ray structure analysis
  379. A new monoclinic polymorph of methylp-aminobenzoate
  380. New thallium(III) chloride complexes with pyridine carboxylic acids: from molecular compounds to supramolecular associations
  381. Synthesis, crystal structures and spectroscopic properties of dichloroethylphenyltin(IV) and its phenanthroline adduct
  382. Dichloro(diphosphine)(2-pyridyl-ketone)ruthenium(II) complexes
  383. New Crystals in the Lithium Sulfate Family.
  384. 3-(5,7-Dimethoxy-2,2-dimethyl-2H-benzo[b]pyran-6-yl)propionic acid: a potential inhibitor against Leishmania
  385. Redetermination of skimmianine: a new inhibitor against the Leishmania APRT enzyme
  386. Redetermination and comparative structural study of isopimpinellin: a new inhibitor against the Leishmania APRT enzyme
  387. New crystals in the lithium sulfate family
  388. Design, Synthesis, and Evaluation of Analogues of 3,3,3-Trifluoro-2-Hydroxy-2-Phenyl-Propionamide as Orally Available General Anesthetics
  389. 3-(Benzoxazol-2-yl)-7-hydroxychromen-2-one methanol solvate
  390. Two members of the bisphosphonate class of drugs: a zwitterion and a molecular compound
  391. 2-Cyano-N-(2-hydroxyphenyl)acetamide
  392. Compositional and Structural Variety of Diphenyllead(IV) Complexes Obtained by Reaction of Diphenyllead Dichloride with Thiosemicarbazones
  393. Structure and magnetism ofMnMgB2O5andMn2B2O5
  394. 17α,21-Dihydroxy-16β-methylpregna-1,4-diene-3,11,20-trione (meprednisone)
  395. 4-(2-Isonicotinoylhydrazino)-4-oxobutanoic acid
  396. Synthesis and characterization of new ruthenium complexes with active ligands against Chagas' disease
  397. Redetermination of nickel bis(dithiocarbamate) at 100 K
  398. Synthesis, Spectroscopic and Structural Aspects of Mono‐ and Diorganothallium(III) Complexes of 2, 6‐Diacetylpyridine Bis(thiosemicarbazone) (H2DAPTSC) — A New Coordination Mode of the HDAPTSC— Anion
  399. 3-Oxoolean-12-en-20-yl α-methylcarboxylate
  400. A novel diterpene lactone
  401. fac-[RuCl3(NO)(dppb)] (I) and mer-[RuCl3(NO)(diop)] (II) complexes: syntheses, characterization and X-ray structures
  402. Novel Organophosphorus Cage Compound Produced by an Unexpected Oxidative Coupling of 1,2,4-Triphosphole: Crystal and Molecular Structures of Two Isomers of Formula P6C4Bu t4 CHSiMe3
  403. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species
  404. Charge density study of hexaaquazinc(II) dihydrogen-1,2,4,5-benzenetetracarboxylate
  405. Supramolecular organization in ruthenium complexes
  406. Supramolecular arrangement in dimethyl thallium complexes through Tl...S
  407. Crystal structure of cobalt-based chain molecular magnet CoCu(opba)(DMSO)3at room temperature and 100 K
  408. New Cages Derived from 1,2,4-Triphosphol
  409. Losartan potassium, a non-peptide agent for the treatment of arterial hypertension
  410. On the lability of dimethylsulfoxide (DMSO) coordinated to the {RuII–NO+} species: X-ray structures of mer-[RuCl3(DMSO)2(NO)] and mer-[RuCl3(CD3CN)(DMSO)(NO)]
  411. Single-crystal structure determination and infrared reflectivity study of the Li2CaHfF8 scheelite
  412. Crystal structure, electrochemical and spectroscopic properties of the trans-K{[FeCl(NO0)(cyclam)]·[FeCl(NO+)(cyclam)]2}(PF6)6 complex
  413. Metal-Induced Cyclization of Thiosemicarbazones Derived from β-Keto Amides and β-Keto Esters:  Open-Chain and Cyclized Ligands in Zinc(II) Complexes
  414. Supramolecular self-assembly in the crystal structures of methylmercury xanthates, MeHgS(S)COR, R=Et, iPr and CH2Ph
  415. Disodium pamidronate
  416. Synthesis and structure of cadmium and zinc complexes of dehydroacetic acid
  417. Epikatonic acid fromAustroplenckia populnea: structure elucidation by 2D NMR spectroscopy and X-ray crystallography
  418. Serendipitous, one-pot formation of 2,3,7-triphenylcyclopenta[c]pyran from 1,2-diphenylethanedione (“benzil”) and cyclopentadiene
  419. Structural Transition and Pair Formation inFe3O2BO3
  420. 6-Deoxyjacareubin
  421. 1-(2-{4-[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiol-3-ylcarbonyl]phenoxy}ethyl)piperidinium chloride
  422. Role of the Hydrogen Bonds in Nitroanilines Aggregation:  Charge Density Study of 2-Methyl-5-nitroaniline
  423. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  424. Structure and properties of iron–cyclam complex of 2-aminophenol
  428. Crystal structure and exchange pathways of the complex l-(trypthophyl-glycinato)copper(II)
  429. A novel coordination mode for a pyridylphosphine ligand. X-ray structures of [RuCl2(NO)L] (I) and [RuCl2(NO)L]·DMSO (II) (L = [(2-py)2PC2H4POO(2-py)2]-)
  430. Hydrogen Bonding in Nitroanilines:  Neutron Diffraction Study of m -Nitroaniline at 100 K
  431. Electrosynthesis of binuclear ruthenium complexes from [RuCl3(dppb)(L)] precursors [L = pyridine, 4-methylpyridine or dimethyl sulfoxide; dppb = 1,4-bis(diphenylphosphino)butane]
  432. Crystal structures of p-chlorobromobenzene and p-chloroiodobenzene
  433. Ba2Cu(HCOO)6, Thermal Behavior and Crystal Structure of the Room Temperature Phase
  434. Experimental evidence for the amino-group non-planarity in nitroanilines: neutron diffraction study of 2-methyl-5-nitroaniline at 100 K
  435. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  436. 3-Aryloxypropiononitriles Intermediates: Crystal and Molecular Structure of 2- and 4-(2-Bromoethoxy)diphenylmethanes
  437. 2,4-Dinitro-N,N-methylphenylaniline
  438. 4-Benzyl-5-ethylthio-3H-1,2-dithiole-3-thione
  439. 2,4-Dinitrophenyl Phenyl Sulfone
  440. 4-Methyl-2-nitroaniline
  441. Structural studies of intermediates in a novel synthesis of aryloxypropiononitriles
  442. Conformational studies of substituted nitroanilines: geometry of 2-methyl-5-nitroaniline
  443. X-ray structural and spectroscopic investigation of 1-piperidine-2,4-dinitrobenzene